MobileWave Group plc ("MobileWave" or the "Company") Issue of Equity The Board is pleased to announce that as a result of the ongoing investment in the Company by Dutchess Opportunity Cayman Fund Ltd ("Dutchess") announced on 06 October 2011 the Company is issuing a further 6,250,000 new ordinary shares in the Company to the Dutchess. Under the Investment Agreement entered into by the Company and Dutchess, Dutchess agreed to subscribe for up to £4.0 million of new ordinary shares in the Company over a period of three years. Accordingly, application has been made for the 6,250,000 new ordinary shares to be admitted to trading on AIM and it is expected that admission will take place on 7 February 2012. The new ordinary shares will rank pari passu with the existing shares of the Company. Following this allotment, the total issued share capital of the Company will increase to 91,082,769 ordinary shares. For further information, please contact: MobileWave Group plc rstear@mobilewave.com Rory Stear, Chairman Charles Stanley Securities 020 7149 6000 Nominated Adviser & Broker Dugald J.Carlean / Carl Holmes
Mediwatch PLC Final Results RNS Number : 5486W Mediwatch PLC 01 February 2012  Mediwatch Plc Final Results for year ended 31 October 2011 Increased profits and cash flow during delayed economic recovery Mediwatch Plc (AIM: MDW, 'Mediwatch' or 'the Company' or 'the Group'), the innovative urological diagnostic company, announces its final results for the year ending 31 October 2011. Financial highlights - Sales revenues at £10.6m (2010: £10.5m) - Increased EBITDA for the year of £713,000 (2010: £583,000) - Increased profit before taxation for the year of £322,000 (2010: £233,000) - Increased cash flow from operations of £835,000 (2010: £581,000) - R&D capitalised expenditure steady at £770,000 (2010; 742,000) Operational highlights - Profits and cash flows have increased due to the re-organisation that commenced in Q1 2011, including the outsourcing of major parts of manufacturing. The re-organisation has enabled Mediwatch to continue to invest in new markets, products and services. - PSAwatch is at early stage of commercialisation with clinical trials in France to gain reimbursement approval, direct marketing starting in Germany, Hong Kong, Mexico and China, growing sales in the UK private sector and the potential for further co-operation and trials with two international pharmaceutical companies. - Significant sales growth (75%) in developing markets (Far East and Russia), providing an excellent platform for further growth, balancing the detrimental effects of the Arab Spring. - Enrolment in the US Federal Government GSA contract allowing sales into Federal Government hospitals including the Veterans Administration network and various private buying groups. - Mobilewatch is making great strides and has increased its turnover three fold in the last 3 months. - Continued strengthening of the product range and partnership with EBNeuro S.p.A. for the exclusive distribution of its gastro and neuro-physiology products in the UK. - New $2,000,000 banking facility with Fifth Third Bank to support growth in the key US market. - Strengthened management team with new operational management in the UK and the USA. Omer Karim, Mediwatch Chairman said: "In spite of Mediwatch's major markets in Europe and the USA suffering from economic turbulence, I am pleased to report that Mediwatch has maintained its turnover and materially increased profits and cash flows from operations during the year. The improved profitability is a result of the cost reduction programme that occurred during the year to re-align operations, including the outsourcing of major elements of our manufacturing and the reduction of fixed overheads, Looking forward, we will continue to focus on internal efficiencies and the tight management of our cost base. During
Got stung big time on this one, bought in at 1.8 ouch!!!!!!!!!!
Any predictions to what the sp will be at the end of play today or friday
Hi nootame, Click on the below link and type in your ticker code and follow the instructions. Good Luck...
What a crazy few days, bought at 1.38 and sold at 5.2, great return it's a shame I'm off to the states tomorrow as i'd keep it going, Good Luck everyone still in. MT
whats the predictions for next week?